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Abstract
Background: Myelin is a multilayered proteolipid sheath wrapped around selected axons in the nervous system. Its
constituent proteins play major roles in forming of the highly regular membrane structure. P2 is a myelin-specific
protein of the fatty acid binding protein (FABP) superfamily, which is able to stack lipid bilayers together, and it is a
target for mutations in the human inherited neuropathy Charcot-Marie-Tooth disease. A conserved residue that has
been proposed to participate in membrane and fatty acid binding and conformational changes in FABPs is Phe57.
This residue is thought to be a gatekeeper for the opening of the portal region upon ligand entry and egress.
Results: We performed a structural characterization of the F57A mutant of human P2. The mutant protein was
crystallized in three crystal forms, all of which showed changes in the portal region and helix α2. In addition, the
behaviour of the mutant protein upon lipid bilayer binding suggested more unfolding than previously observed for
wild-type P2. On the other hand, membrane binding rendered F57A heat-stable, similarly to wild-type P2. Atomistic
molecular dynamics simulations showed opening of the side of the discontinuous β barrel, giving important
indications on the mechanism of portal region opening and ligand entry into FABPs. The results suggest a central
role for Phe57 in regulating the opening of the portal region in human P2 and other FABPs, and the F57A mutation
disturbs dynamic cross-correlation networks in the portal region of P2.
Conclusions: Overall, the F57A variant presents similar properties to the P2 patient mutations recently linked to
Charcot-Marie-Tooth disease. Our results identify Phe57 as a residue regulating conformational changes that may
accompany membrane surface binding and ligand exchange in P2 and other FABPs.
Keywords: Myelin, Crystal structure, Fatty acid-binding protein, Membrane binding, Molecular dynamics, Mutation,
Protein stability
Background
A multitude of proteins interact with lipid membrane
surfaces. These peripheral membrane proteins come
from various protein families, and have generally little in
common at the structural level. Both electrostatic and
hydrophobic interactions are important for protein bind-
ing onto membranes. Conformational changes in the
protein are often observed upon membrane binding and
embedding, and the dynamics of both the protein and
lipid components may be altered upon proteolipid com-
plex formation. The proteins of the myelin sheath are in
intimate contact with lipid membranes, being either per-
ipheral or integral membrane proteins [1]. Defects in
myelin protein structure and/or function are linked to
various chronic demyelinating conditions, such as mul-
tiple sclerosis and peripheral neuropathies.
Peripheral myelin protein P2 is one of the most abun-
dant proteins in human peripheral nervous system
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(PNS) myelin [2]. P2 is expressed inhomogeneously
along myelinated axons: it can reach 15% of total myelin
protein in selected areas in the PNS, and it is also
expressed in the central nervous system in small
amounts in the spinal cord and brain stem [2–4]. The
physiological role of P2 remains unclear, even though it
is expressed at such high levels in myelin. P2 is located
in compact myelin, and it is expressed more in large
axon myelin [3, 5]. P2 has the ability to stack membrane
leaflets together [6, 7], and a dysfunction of P2 may lead
to myelin degeneration. Recently, three point mutations
in human P2 were linked to Charcot-Marie-Tooth dis-
ease (CMT), an inherited neuropathy [8–10]. We
showed that these mutations all decrease the stability of
P2, although they did not lead to major differences in
the P2 fold in the crystal state [11]. The disease muta-
tions also slightly altered membrane binding properties
of P2 [11].
The structure of human P2 has been solved at 0.93-Å
resolution using X-ray crystallography [12]. P2 belongs
to the fatty acid binding protein (FABP) family, and the
structure of P2 is typical for FABPs [13, 14]: the body of
P2 is a barrel formed of 10 antiparallel β strands, and
the loops that connect the β strands cover the open ends
of the barrel. The loop between the first two strands is
extended with two antiparallel α helices that form a
lid-like cover for the open end of the barrel. Inside the
barrel, there is a large ligand binding pocket, typical for
FABPs [13, 14]. The β barrel is discontinuous, with no
main-chain hydrogen bonds present between β strands 4
and 5. This feature is common to the entire FABP fam-
ily, suggesting structural and/or functional importance.
During myelination, large-scale membrane synthesis
takes place, and both protein and lipid components need
to be transported to the correct location [15, 16]. P2
could, in addition to being a structural component of
the myelin sheath, be important for transporting lipidic
compounds into the myelin membrane. For example,
myelin is rich in cholesterol [17], and P2 might function
as a cholesterol transporter. Studies on P2-deficient mice
showed a mild effect on nerve conduction velocity and
an abnormal lipid composition during the period of
most active myelination, although the ultrastructure of
PNS myelin appeared visually normal [4]. A recent
follow-up study identified a role for P2 in remyelination
after nerve injury [18].
FABPs are small β barrel proteins that can function as
lipid transporters [19]. They can roughly be divided into
two groups based on their respective transport mecha-
nisms [20, 21]. P2 is a member of the group employing
collisional transfer upon interaction with a lipid mem-
brane. The other group includes e.g. liver FABP, having a
diffusive transfer mechanism, whereby the FABP spon-
taneously opens and closes to allow ligand exchange
[20]. P2 is unique in the FABP family, as it apparently
has a stable contact to membranes, and it can stack lipid
bilayers into highly ordered multilayers [6, 12]. Dynam-
ics of the so-called portal region, consisting of helix α2
and the loops β3-β4 and β5-β6, have been identified
as a key determinant of ligand binding-related con-
formational changes in the FABP family, although
differences in this behaviour are apparent between
family members [22, 23].
Here, we specifically focused on the conserved FABP
family residue Phe57 in human P2. Phe57 is in a central
position in the portal region, and it is believed to regu-
late ligand entry into the internal cavity in FABPs [24].
Mutagenesis of Phe57 into alanine (F57A) highlighted
specific roles for Phe57 in ligand binding and structural
integrity of the portal region. Stability and membrane
binding of P2 were affected by the F57A mutation simi-
larly to the CMT-linked point mutations. Furthermore,
molecular dynamics (MD) simulations of the F57A mu-
tant showed opening of the β barrel from the side, which
is likely to be a general mechanism for FABP portal re-
gion opening. The regulation of this conformational
change appears to be affected in mutant variants of P2.
Methods
Protein production and crystallisation
Wild-type P2 (wt-P2), as well as the F57A and P38G var-
iants, were produced as earlier described [14, 25, 26].
Briefly, the proteins were expressed as His-tagged fusion
proteins in E. coli using autoinduction [27], and they
were purified with immobilized metal ion affinity chro-
matography (IMAC) and size exclusion chromatography
(SEC). The His tag was cleaved with TEV protease, and
IMAC and SEC were further used to obtain highly pure
protein. Crystallization of the F57A mutant has been de-
scribed [26]. Two additional crystal forms were obtained
here; all crystallization conditions were similar, contain-
ing 40–42% PEG6000 at pH 6.0–7.0 (see results for de-
tails). Crystallization was done at + 4 °C.
Crystallographic data collection and structure refinement
Diffraction data were collected on the EMBL beamline
X12 at the DORIS synchrotron storage ring (DESY,
Hamburg). 20% PEG200 was used for cryoprotection,
prior to transferring the crystals to liquid nitrogen
temperature. Data were collected at 100 K. The data
were processed with XDS [28] and XDSi [29]. The
structures were solved with molecular replacement
using PHASER [30], using the wild-type P2 structure
[14] as template, and refinement was carried out in
phenix.refine [31]. Model building was done in coot
[32] and validation in MolProbity [33]. The structures
were deposited at the PDB with entry codes 6EW2,
6EW4, and 6EW5.
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Lipid preparation
For stock solutions, dimyristoylphosphatidylcholine (DMPC)
and dimyristoylphosphatidylglycerol (DMPG) (Larodan Fine
Chemicals AB, Malmö, Sweden) were dissolved in chloro-
form:methanol (9:1 v/v) at 10–40 mg/ml final concentra-
tions, and combined to reach an equimolar mixture
(DMPC:DMPG (1:1)). Stock solutions and equimolar mixes
of dioleoylphosphatidylcholine (DOPC) and dioleoylpho-
sphatidylserine (DOPS) (Avanti Polar Lipids, Alabaster, Ala-
bama) were prepared similarly, but without methanol. The
mixtures were divided into aliquots, which were dried
under a nitrogen stream at ambient temperature,
followed by lyophilization overnight at − 52 °C under
vacuum. The dried lipids were stored at − 20 °C until
further use. To prepare lipid vesicles, 20 mM HEPES,
150 mM NaCl, pH 7.5 was added directly onto the
dried lipids to obtain 5–7 mM concentration. Gentle
agitation was applied overnight at ambient temperature.
Large multilamellar vesicles (MLVs) were prepared
from the suspensions by freeze-thawing 7 times using
liquid nitrogen and a warm water bath, followed by vig-
orous vortexing. Large unilamellar vesicles (LUVs) were
prepared by passing the MLVs through a 100-nm mem-
brane 11 times, while heating to + 40 °C. All vesicle
preparations were used immediately in downstream
experiments.
Circular dichroism spectroscopy
A Chirascan Plus instrument (Applied Photophysics)
was used for circular dichroism (CD) spectroscopy. CD
spectra were measured at + 20 °C in a 0.5-mm quartz
cuvette. Protein concentration was 0.25 mg/ml (14 μM)
in 0.8 mM HEPES pH 7.5, 6 mM NaCl, 0.4% glycerol. In
mixtures with lipids, the lipids (DMPC/DMPG at 1:1
mixture) were in 100-fold molar excess (1.4 mM).
Temperature scans, at a heating rate of 1 °C/min, were
run for the same samples between + 20 − + 90 °C. Full
spectra were continuously measured as a function of
temperature. Temperature scan data were analyzed
using Global3™ (Applied Photophysics).
Atomistic molecular dynamics simulations
The crystal structure of P2-F57A was subjected to atom-
istic MD simulations exactly as previously described [11,
25] for wt-P2 and P2-P38G. Simulations were carried
out in the presence and absence of bound palmitate, in a
simulation box filled with TIP3P water molecules.
Briefly, the system was energy-minimized with the stee-
pest descent algorithm and then simulated for a total of
3 μs. MD simulations were run with GROMACS 4.6.7
[34]. The last 2.5 μs were used for analyses. Dynamic
cross-correlation map (DCCM) analysis was performed
using Bio3D [35].
Differential scanning calorimetry
Differential scanning calorimetry (DSC) was carried out
essentially as earlier described for myelin basic protein
(MBP) [36]. P2 and P2 F57A were mixed with MLVs of
350 μM DMPC:DMPG (1:1) in 20 mM HEPES, 150 mM
NaCl, pH 7.5, at 1:100 and 1:200 protein-to-lipid (P/L)
ratios. The samples were degassed for 10 min under vac-
uum with stirring at + 10 °C before measurements. A
control lipid sample without protein was also prepared.
DSC measurements were performed with a MicroCal
VP-DSC instrument. Cell volume was 527.4 μl. The ref-
erence cell was filled with 20 mM HEPES, 150 mM
NaCl, pH 7.5. Each sample was scanned from + 10 to +
40 °C and back to + 10 °C in 1 °C/min steps. Buffer base-
lines were subtracted from sample curves and zeroed be-
tween + 28–30 °C. All samples were prepared and
measured twice and deemed reproducible.
Membrane surface binding
Surface plasmon resonance (SPR) was performed as de-
scribed [11, 36]. Briefly, SPR measurements were per-
formed using a Biacore T200 system (GE Healthcare)
using 20 mM HEPES, 150 mM NaCl, pH 7.5 as running
buffer at + 30 °C. LUVs of 1 mM DOPC:DOPS were
immobilized on an L1 sensor chip (GE Healthcare),
followed by a blocking injection of 0.2 mg/ml BSA, and
a single injection of P2 or P2 F57A. Chip regeneration
was performed using a 2:3 (v:v) mixture of isopropanol
and 50 mM NaOH. The studied protein concentrations
were 0.1–15 μM. A single concentration was analyzed
per cycle, and all samples were measured in duplicate.
Equilibrium binding responses were plotted against pro-
tein concentration and fitted using a one-site binding
model (Y = Bmax*X / (Kd + X)).
Lipid vesicle aggregation
Turbidimetry was used to follow vesicle aggregation, a
sign of lipid membrane stacking by P2, as described be-
fore [11, 12, 37]. LUVs of 500 μM DMPC:DMPG (1:1)
were mixed with 0.5–10 μM P2 or P2 F57A in 100-μl
triplicate samples. Turbidity at 450 nm and 660 nm was
recorded immediately after sample preparation and mix-
ing at + 30 °C using a Tecan SPARK 20 M plate reader
for 15 min. The mixtures were stored overnight at + 4 °
C for further co-sedimentation analysis.
Protein-lipid co-sedimentation
To check for protein co-sedimentation with the lipid
vesicles, samples were picked from the 10 μM vesicle ag-
gregation samples, combined, and centrifuged at
16000 g, + 4 °C for 10 min to separate the lipid-bound
protein from soluble protein. The pellet was resus-
pended in 20 mM HEPES, 150 mM NaCl, pH 7.5. The
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protein content of the supernatant and the pellet sus-
pension was analyzed using SDS-PAGE.
In addition, co-sedimentation assays were separately
carried out using 20 μM wt-P2 mixed with 1 mM
DMPC:DMPG (1:1) or DOPC:DOPS in 20 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 0.5 mM TCEP. After
a 30-min incubation at ambient temperature, the sam-
ples were subjected to ultracentrifugation for 75 min at
435000 g at + 20 °C. The supernatant and pellet were an-
alyzed by SDS-PAGE.
Bioinformatics
Using the crystal structure of wt-P2 [14] and all the six
independent F57A crystal structures described here, resi-
due interaction networks (RINs) were generated with
Chimera [38] through the structureViz [39] app for
CytoScape [40], using default parameters without hydro-
gen bonds, and with own contact detection software
(2.5–5 Å). RIN analyses were performed with the
RINspector [41] app for CytoScape. They included be-
tweenness and residue centrality analysis. Only Z scores
of ≥2 were considered relevant. The analyses were car-
ried out with and without the bound palmitate ligand;
the ligand dominated the networks when present.
Sequence-based predictions of protein flexibility were
done using DynaMine [42, 43]. Structure-based predic-
tion of point mutation effects on P2 thermal stability
was done with Cupsat [44] and MAESTRO [45].
Results
Myelin P2 folding and stability
The F57A and P38G mutants were compared to wt-P2
using CD spectroscopy (Fig. 1a). In solution, all three
variants had similar CD spectra, indicating no
large-scale structural effects by the mutations. This was
earlier confirmed for the P38G mutant [25]. A large ef-
fect on the CD spectra of membrane-bound P2 was in-
duced by both mutations (Fig. 1b), and difference
Fig. 1 Analysis of P2 folding by CD spectroscopy. a Comparison of CD spectra of wt-P2, P2-F57A, and P2-P38G. The spectra for wt-P2 and
P2-P38G were presented earlier [25]. b Spectra for the same P2 variants in the presence of lipids. The dashed lines indicate difference spectra
between wt-P2 and each mutant. c Stability analysis of P2-F57A by CD in solution. CD spectra are shown from + 20 (black) to + 90 °C (blue), at
intervals of 10 °C for clarity. The spectrum at + 50 °C is shown in red to aid in comparison between samples. d Stability of P2-F57A in the
presence of lipids. Inset: CD signal at 200 nm of wt-P2 (black), F57A (red), and P38G (green) bound to lipids as a function of T
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spectra indicate that the mutant variants contain less
overall secondary structure than wt-P2.
Thermal CD scans were further employed to follow ef-
fects of the two mutations on P2 heat stability. In our
previous study, we saw a decrease in stability for the
P38G mutant [25]. Here, a lowered melting point of the
P2-F57A protein was observed compared to wt-P2.
The secondary structure content of P2 changes once
mixed with DMPC:DMPG vesicles (Fig. 1b). The
temperature scans were repeated with proteins in a lipid
environment: wtP2 did not get fully denatured even at +
90 °C, only a conformational shift to a more helical struc-
ture was observed [12]. The same behaviour, but including
more unfolding, was observed for P2-F57A (Fig. 1c,d).
The different behaviour of wild-type and mutant P2 in
solution and in the presence of lipid vesicles shows a
strong effect on P2 stability and properties by lipid
membrane binding. In solution, both wt-P2 and the mu-
tants show very well-defined isosbestic points (Fig. 1c),
indicative of a simple two-state unfolding reaction; even
though the melting temperatures are different. However,
in the presence of membranes, the spectral changes are
gradual, and isosbestic points are not present at all (Fig.
1d). This is a sign of a complex stepwise conformational
adaptation to the membrane environment by P2 as a
function of temperature. A main change occurs in the
range of + 50 °C, and actually at a lower temperature for
wt-P2 (Fig. 1d, inset). After this transition, wt-P2 re-
mains stable, while the mutants gradually change their
structure even as temperatures approach + 90 °C; how-
ever, all the proteins remain in a folded state even at
these high temperatures in the presence of lipids. Inter-
estingly, the conformational changes start to be visible
around physiological temperature.
Membrane binding and stacking by P2-F57A
When P2 is mixed with lipid vesicles, visible aggregation
occurs, which can be quantified using turbidimetry [11,
12]. Turbidity can be used as a means to quantify the
function of myelin proteins - binding lipid membranes
together [36, 37]. At time point 0 of the vesicle aggrega-
tion experiments, there is only a marginal difference be-
tween P2 and the mutant, when the P/L ratio changes
(Fig. 2a). As a function of time, it seems that the proteo-
lipid aggregate stability is higher for wt-P2 (Fig. 2b).
F57A reaches its maximum level quicker, but also de-
creases over time. This suggests differences in vesicle ag-
gregation kinetics between wt-P2 and P2-F57A, which
may be linked to effects on the P2 membrane binding
mechanism by the mutation. The co-sedimentation of
wt-P2 and F57A with lipids is similar (Fig. 2c). Electro-
phoretic analysis of the proteolipid pellet also occasion-
ally reveals a ladder of different oligomeric forms of P2
in the protein-lipid pellet (Fig. 2d).
Using DSC, we followed the lipid tail phase transition
of DMPC:DMPG vesicles in the presence and absence of
P2 (Fig. 2e). The lipid phase transition behaviour is al-
tered by P2, and upon addition of wt-P2, the main tran-
sition population decreases and a wide, fairly
low-intensity population at + 25.5 °C is formed. The ef-
fect is dependent on P2 concentration. Earlier, we
showed similar effects by MBP on negatively charged
vesicles [36]. However, the F57A mutant does not show
this behaviour, and the phase transition is not much
affected.
We further studied the affinity of P2 towards DOPC:-
DOPS membranes using SPR (Fig. 2f,g). The mutant
seems to have a slightly lowered affinity for DOPC:-
DOPS (1:1) LUVs (Table 1), while the maximum amount
of protein bound to the surface is similar. In addition, as
seen before for the CMT disease mutant variants [11],
the binding kinetics for F57A are different from wt-P2;
apparently both binding and dissociation occur more
slowly with the mutant protein.
Structure of P2 F57A mutant in the crystal state
P2-F57A was crystallized in three different crystal forms
under similar conditions (Table 2), and the crystal struc-
ture was solved from all of them. Phe57 lies at the tip of
the β3-β4 loop, close to the bound fatty acid. The fatty
acid, originating from the E. coli expression host, was
modelled as palmitate. Phe57 forms C-H...π interactions
with the nearby residues Lys58 and Leu32 that lie on op-
posite sides of the Phe ring (Fig. 3a).
In line with CD spectroscopy, no large-scale changes
in P2 structure were induced by the mutation in the
crystal state. Once the C-H...π interaction gets elimi-
nated in P2-F57A, both helix α2 and the β3-β4 loop alter
their positions: helix α2 turns inwards towards the
palmitate bound in the cavity, and the β3-β4 loop bends
outwards, slightly opening the portal region (Fig. 3b). In
different crystal forms of P2-F57A, helix α2 and loop
β3-β4 are in slightly different conformations. The bound
fatty acid adopts a more elongated conformation in
F57A-P2 than in wild-type P2, correlating with the con-
formation of the β3-β4 loop (Fig. 3b). Strands β4 and β5
do not have any main-chain H bonds between them, and
a line of water molecules mediates contacts between
them (Fig. 3c).
Molecular dynamics simulations
In atomistic simulations of wt-P2 in solution, the Phe57
side chain alters its conformation occasionally, flipping
outwards and pointing towards bulk solvent (Fig. 4a,b).
Such conformations have been seen before in crystal
structures of FABPs, including P2 [46]. Phe57 side chain
flipping is apparently more frequent and lasts a longer
time in the presence of bound fatty acid (Fig. 4a).
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The F57A simulations presented here revealed a
large-scale opening of the β barrel between strands β4 and
β5 (Fig. 4c,d,e). Upon this opening, the ligand-binding
cavity becomes accessible, as the hairpin unit formed by
strands β5 and β6 flaps out. Based on the F57A simulation
results, we re-analyzed our earlier simulations of WT and
P38G P2 [25], and indeed, for both of them, an occasional
opening of the β barrel at the same site is observed, with
exposure of the bound ligand (Fig. 4d). This was especially
prominent for the palmitate-bound P38G mutant, which
we observed to have higher dynamics than the wild-type
protein.
An analysis of the root mean-square fluctuations in the
MD trajectories reveals that F57A shows higher dynamics
than wt-P2 in the absence of fatty acid (Fig. 4f), while dy-
namics are identical in the presence of bound ligand. Spe-
cifically, the site of the F57A mutation is not much affected,
but the β5-β6 and β7-β8 loops are more mobile, indicating
an increased flexibility of the portal region in the mutant.
For additional insight into concerted dynamics of
P2, DCCM analyses were performed on the MD tra-
jectories (Fig. 5). While wild-type P2 shows strong
anti-correlation between the β5-β6 loop and the rest
of the portal region (helices α1-α2 and the β3-β4
loop), no such correlation exists in the F57A mutant.
Similar results were obtained with and without bound
palmitate (Fig. 5). In addition, we analyzed our earlier
MD trajectories for the CMT disease mutations [11]
as well as P38G [25]. All the mutations had similar
effects to F57A, indicating loss of anti-correlations in
portal region dynamics (Additional file 1: Figure S1).
Table 1 SPR fitting parameters of P2 binding to DOPC:DOPS
(1:1) vesicles
Protein Bmax (R.U.) Kd (μM) R
2
P2 1466 ± 54 3.1 ± 0.3 0.9750
P2-F57A 1408 ± 56 6.2 ± 0.5 0.9884
Fig. 2 Lipid binding experiments. a wt-P2 (black) and P2-F57A (red) initial vesicle aggregation profiles as a function of protein concentration.
b Decrease in the turbidity signal over time in the mutant sample. c Co-sedimentation at 1:100 P/L (10 μM protein with 1 mM DMPC:DMPG)
suggests roughly 50% binding of protein to vesicles. 1, molecular weight marker; 2, wt-P2 in pellet; 3, P2-F57A in pellet; 4, wt-P2 supernatant; 5,
P2-F57A supernatant. d Co-sedimentation of wt-P2 with lipid vesicles. 1–2, supernatant and pellet of 20 μM P2 with 1 mM DMPC:DMPG; 3–4
supernatant and pellet of 20 μM P2 with 1 mM DOPC:DOPS. The asterisks indicate the positions of monomeric (*), dimeric (**), and trimeric (***)
P2 in the proteolipid pellet. e DSC measurements show the diminished effect of the F57A mutant (red) on the lipid phase transition behaviour,
while wt-P2 (black) has a clear effect. Dotted line: lipids alone, dashed line: P/L 1:200, solid line P/L 1:100. f Examples of SPR sensorgrams; shown
are duplicate injections of 10 μM wt-P2 (black) and P2-F57A (red) onto immobilized DOPC:DOPS (1:1). g The steady-state affinity of the F57A
mutants to DOPC:DOPS (1:1) vesicles is marginally weaker compared to wild type. All error bars are standard deviations
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Predictions and network analyses
Flexibility predictions were carried out based on the P2
sequence, to compare the predicted effects of F57A and
the CMT disease mutations. Each of the mutations is
predicted to cause a local increase in flexibility (Fig. 6a,b).
This is in line with the observed decrease in heat stabil-
ity and the increased dynamics in simulations for the
mutant variants. Based on the P2 crystal structure, we
further predicted the effects of the mutations on protein
stability (Table 3); overall, the predictions fit the mea-
sured decrease of Tm for the mutants. This result further
shows that the F57A mutation behaves similarly to the
disease mutations in structure-function assays.
For a deeper understanding of P2 folding and intramolecu-
lar interactions, residue interaction networks and centralities
in the crystal structures were characterized and compared
between wt-P2 and P2-F57A; all six independent F57A mole-
cules in the three crystal structures with different space
groups were included in the analysis. The analysis shows that
Phe57 is structurally not a very central residue in the P2
structure, and its mutation to alanine has subtle effects on
these networks (Additional file 2: Figure S2). This observation
is slightly unexpected, having experimentally seen a drastic
drop in thermal stability in the F57A mutant protein (see
above). Interestingly, a group of residues, including the dis-
ease mutation sites, as well as residues on strand β4 and in
Table 2 Data processing and structure refinement statistics for P2-F57A
Space group P43212 C2 [26] P212121
Unit cell dimensions a = b = 58.61 Å, c = 76.96 Å α = β = γ = 90° a = 112.76 Å, b = 36.08 Å, c = 31.17 Å,
α = γ = 90°, β = 96.87°
a = 52.12 Å, b = 76.11 Å,
c = 138.43 Å, α = β = γ = 90°
Wavelength (Å) 1.10 1.10 1.10
Resolution range (Å) 20–1.59 (1.63–1.59) 20–1.27 (1.30–1.27) 20–1.95 (2.00–1.95)
<I/σ(I)> 19.1 (1.0) 8.2 (1.2) 11.6 (2.3)
Rsym (%) 6.5 (111.4) 7.6 (60.7) 15.8 (75.0)
Rmeas (%) 7.2 (129.6) 9.2 (78.1) 17.3 (82.1)
Completeness (%) 98.7 (92.7) 96.8 (77.4) 99.1 (98.7)
Redundancy 5.7 (3.2) 2.9 (1.8) 6.0 (6.0)
CC1/2 (%) 99.9 (39.9) 99.6 (43.6) 99.4 (75.4)
Wilson B factor (Å2) 27.2 16.9 20.2
Rcryst (%) 18.6 17.1 18.8
Rfree (%) 21.6 22.4 23.6
rmsd bond lengths (Å) 0.012 0.009 0.005
rmsd bond angles (°) 1.3 1.2 0.9
Ramachandran favoured/allowed (%) 100/100 99.3/100 98.1/100
# molecules in asymmetric unit 1 1 4
MolProbity score (percentile) 1.25 (97th) 1.48 (79th) 1.32 (99th)
PDB entry 6EW2 6EW4 6EW5
Fig. 3 Phe57 in the P2 crystal structure. a The location and interactions of Phe57 in wt-P2. Note the C-H...π bonds on both faces of the Phe57
side chain. b Conformational effects of the F57A mutation (stereo view). Superposed are wt-P2 (magenta) and all individual P2-F57A monomers
from the three crystal forms (6 in total). Note the apparent flexibility of helix α2 and the β3-β4 loop. c Discontinuity of the β barrel of P2; a line of
water molecules mediates contact between strands β4 and β5
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the β5-β6 unit, become more central upon the F57A
mutation (Fig. 6c and Additional file 2: Figure S2).
Leu32 on helix α2 also belongs to this group. Also
the interactions between P2 and the palmitate ligand
are slightly altered through the mutation, in line with
the subtle conformational changes observed in the re-
spective crystal structures.
When the palmitate ligand is included in the analysis, it
dominates the network, highlighting its multiple interac-
tions and suggesting a stabilizing and therefore possible
structural role in P2 and the FABP superfamily protein
stability (data not shown). The two Arg residues coordin-
ating the palmitate anionic group are central in P2 intra-
molecular networks, when the palmitate is not taken into
account. Additional central P2 residues can be observed.
Some of them, especially Gln93 and Gln95, both pointing
inwards on strand β7 (Fig. 6c and Additional file 2: Figure
S2), have not been of obvious importance in earlier ana-
lyses of P2 crystal structures. Gln93 is sandwiched be-
tween the charged side chains of Arg106 and Glu72 (close
to the β5-β6 loop) - both carrying buried charges inside
the protein. Importantly, none of the central residues of
wt-P2 lie in the β5-β6 unit, which flips out during barrel
opening (Fig. 6c).
Discussion
While the FABP family contains proteins with distinct
functions, current evidence suggests that the FABPs
Fig. 4 MD simulations of P2-F57A. a Fluctuation of the distance between Phe57 and helix α2 shows flipping of the Phe57 side chain in wt-P2
during the simulation. The simulation was run with (magenta) and without (black) the fatty acid ligand. b The two conformations of Phe57
(cyan). Left: Phe57 points inwards and interacts with the fatty acid (magenta). Right: Phe57 points outwards. Bovine P2 crystal structure is shown
superposed in yellow, with the same conformation. c The structure shows the distance measured when studying barrel opening. d Distance
between the tips of the β3-β4 and β5-β6 loops during the simulation. Black: wt-P2; red: F57A; green: P38G. Left: simulations without ligand. Right:
simulations with bound palmitate. The red and green arrows indicate the positions of the snapshopt in the next panel. e Structural snapshots
from the simulations. Left: Closed starting structure for F57A; middle: open F57A structure at 1.5 μs; right: open P38G structure with ligand at
2.2 μs, identified from our earlier trajectories [25]. f RMSF of wt-P2 (black) and F57A (red) in the simulations. Thick lines indicate unliganded
simulations and thin lines those with bound fatty acid
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share not only structural, but also dynamical, properties.
Phe57 is a highly conserved residue in the FABP family,
thought to play an important role in the function of the
portal region and ligand binding [24, 47, 48]. Its con-
formation varies between FABP crystal structures, being
either swung in to interact with the hydrophobic ligand
and helix α2 or pointing towards the solvent. In struc-
tures of P2, Phe57 is normally pointing inwards, making
direct van der Waals contacts with the hydrocarbon tail
of the bound fatty acid, although the first structure of
bovine P2 had Phe57 pointing outwards [46]. We stud-
ied the importance of Phe57 in human myelin P2 pro-
tein through a variety of biophysical experiments.
P2 stability and folding
We showed before that binding of wt-P2 to lipid vesicles
induced an apparent unfolding of helical structures, i.e.
the lid of the β barrel [12]. Hence, we wanted to observe
any potential effects on this unfolding by two mutations
at the portal region, F57A and P38G. We showed that
the P38G mutation renders the P2 protein more dy-
namic on different time scales [25]. The folding of both
of the mutant proteins was affected by the presence of
lipid vesicles more than that of the wild-type protein.
Thermal stability of both mutant P2 variants was de-
creased. For P38G, a flexibility increase in loop areas
and helix α2 was also observed in computer simulations
Fig. 5 DCCM analysis of MD trajectories. a wt-P2 without fatty acid. Note the two regions of strong anti-correlation (arrows). b wt-P2 with
palmitate. c P2-F57A without ligand. d P2-F57A bound to palmitate
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[25], and for P2-F57A, the diversity in crystal structures
indicates increased protein flexibility in the portal region.
Previously, for wt-P2 it appeared that binding to phos-
pholipids would result in the unfolding of helices [12],
whereas the P2 N-terminal peptide was shown to be-
come helical when bound to lipids [14]. It is clear that
binding to phospholipids increases P2 thermal stability
drastically as a result of an interaction between the
phospholipids and P2. This interaction can partially
overcome the destabilizing effects of point mutations on
the protein in solution. All in all, F57A behaves similarly
to both P38G as well as the CMT-linked disease muta-
tions [11, 25].
Membrane binding and stacking
Many FABPs have been shown to interact with lipid
membranes [49–55]. For those FABPs employng a colli-
sional transfer mechanism, such interactions are func-
tionally crucial [49]. To our knowledge, however, P2 is
the only member of the FABP family that stacks lipid
membranes into multilayers; hence, one can expect its
structure-function relationships to differ somewhat from
other FABPs.
P2 bound to lipid membrane surfaces, and electro-
phoretic separation often resulted in a ladder of P2 in
the membrane pellet. This reflects a very tight inter-
action of P2 with stacked membranes, not being dis-
sociated by SDS and heating, and suggests the
formation of supramolecular complexes by P2 mole-
cules and two apposing lipid membranes. The struc-
tural details of this assembly are likely to be relevant
for myelin formation, and further research will be re-
quired to elucidate the molecular architecture, also
with respect to other myelin proteins present in the
same compartment, such as MBP and P0.
Our DSC experiment indicated effects by P2 on lipid
phase transition similar to those we observed with MBP
[36]. The effect was, however not observed for P2-F57A
here. This means that the insertion or hydrophobic ef-
fect of the protein – or the formation of lipid rafts or
structures that have altered phase transition behavior –
is not present with the mutant.
Crystal structures of P2-F57A
Phe57 is a conserved residue in most FABPs, and its sta-
bilizing interactions may be a common feature of FABPs
[12]. The conservation concerns especially FABPs thought
to transfer ligands to membranes through the collisional
mechanism. It is possible that upon membrane binding,
these interactions are altered, allowing for conformational
changes in the portal region of FABPs.
Fig. 6 Flexibility and contact network analysis. a. DynaMine prediction of F57A flexibility. b. DynaMine prediction of flexibility of the CMT disease
mutations in P2. Our residue numbering differs by − 1 from the mutation reports, to comply with the conventional numbering of residues in P2
and other FABP structures. c. Mapping of central residues onto the P2 structure. The structure shown is the liganded structure of the P38G
mutant during MD simulations, to highlight the opening. The centralities were calculated from the unliganded crystal structures. The bound fatty
acid is shown as a magenta surface and Phe57 in orange. Residues having high Z scores of centrality are indicated in blue, and the ones showing
higher centrality in F57A than the wild-type P2 in yellow. Note how the opening β flap has no residues of high centrality (red circle). See
Additional file 1: Figure S1 for more details
Table 3 Predicted and measured changes in heat stability for
various P2 variants. Tm values for P38G and the disease







F57A −1.91 1.16 −6
P38G −5.38 1.64 −6
I43N −7.63 3.92 −17
T51P −1.51 1.43 −24
I52T −5.17 2.89 −13
Note that Cupsat defines a destabilizing mutation with a negative ΔΔG, while
in MAESTRO, a destabilizing mutation has a positive ΔΔG
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The possibility of crystallizing in different conformations
indicates an increasing flexibility of the portal region,
linked to the missing stabilizing C-H…π interactions of
Phe57. The absence of Phe57 seems to both destabilize P2
as well as bring about small but clear conformational
changes in the crystal state. These differences are likely to
correspond to molecular motions upon extrusion of the
ligand from the internal cavity. Phe57 lies close to the
anion-binding pocket we observed previously [12]. In the
structures of the F57A mutant, this pocket is usually occu-
pied by an anionic group in the crystal. We believe this
site can be relevant for membrane lipid headgroup bind-
ing and possible allosteric conformational changes in-
duced thereby.
While fatty acid binding to FABPs in general causes
only little changes in structure and dynamics [23], all ex-
perimental structures of P2 thus far have a bound fatty
acid molecule inside the protein. Thus, comparisons be-
tween liganded and empty P2 cannot be yet done based
on experimental data. MD simulations have shown, both
in the current study and our earlier work [25], that
bound palmitate decreases the overall dynamics of P2.
In all FABPs, the β barrel is in fact discontinuous, and
water molecules between two strands interrupt the
main-chain H-bonds one would expect for a perfect β
barrel. Already since early FABP structures, it has been
suggested that this could be a location of FABP flexibility
and related to the opening of the portal region [56].
P2 dynamics and networks
In earlier coarse-grained simulations, Phe57 was found
to be one of the residues possibly inserting into the
hydrophobic interior of the lipid bilayer [12]. The flexi-
bility of the large Phe57 residue observed in our simula-
tions could be important in the dynamics of the portal
region. Phe57 has been considered a gatekeeper of the
portal region in FABPs [24, 47, 48].
In the F57A simulation, a large opening of the barrel
between strands β4 and β5 was observed. Recently, we
observed the same phenomenon in simulations as well
as experimental SAXS solution studies for the
CMT-linked variants of human P2 [11]. The increased
dynamics of the F57A mutant correlate to the opening
of the β5-β6 unit. We believe to have observed a general
mechanism for opening of the FABP β barrel upon lig-
and exchange; the helical lid does not open in this
process. Earlier studies on different FABPs have identi-
fied slightly varying mechanisms for fatty acid entry and
egress [22, 57, 58]; while in general, opening of the por-
tal region is considered most important, alternative
routes for ligand entry and/or exit have been suggested at
the bottom of the β barrel structure [58]. The significant
opening of P2 at β5-β6 in our extended 3-μs simulations,
which are at least an order of magnitude longer than most
published FABP simulations, suggests this is the main lig-
and entry mechanism in the myelin P2 protein. How the
conformational change is affected by binding to lipid
membranes, remains currently unknown.
DCCM analyses indicated a clear loss of dynamic
anti-correlations between the opening β5-β6 flap and
the rest of the portal region in all analyzed mutants (Fig.
5, Additional file 1: Figure S1); similar results were ob-
tained in both the presence and absence of bound fatty
acid ligand. In wt-P2, this anti-correlation is likely to re-
flect coordinated open-close movements, and it appears
that such coordination is lost in both the disease vari-
ants and the F57A and P38G mutants. These results fur-
ther highlight the important role of Phe57 in regulating
portal region structure and dynamics. While Phe57 does
not directly interact with the β5-β6 loop, its close inter-
action with the α2 helix is likely to be important for this
indirect regulation; this mechanism may be applicable to
also other members of the FABP family.
Similarly to fatty acid binding, also membrane binding
mechanisms of various FABPs have been studied [49–
55]. The binding was suggested to be heavily affected by
macrodipoles present in the protein molecule [53]. The
orientation of the FABP with respect to the membrane
appears to not be conserved between different FABPs,
and docking may occur both through the portal region
or the opposite face [53, 59]. In this respect, it is import-
ant to remember that P2 is bound between two mem-
brane surfaces, and it is likely that both of these modes
are applicable to P2. Our earlier coarse-grained simula-
tions suggested membrane interactions through both the
portal region and the anti-portal bottom face of P2 [12].
Gln93 and Gln95, identified in our network analysis,
could be crucial for correct folding and function-related
conformational changes. Interestingly, alignment of all
human FABPs [12] shows that whenever Glu72 is
present, also Gln95 is conserved. Residue 93 is in these
cases either Gln, His, or Cys; when it is a Cys, residue
106 is Gln instead of Arg. Thus, a residue at position 93
interacts with a buried charge on the β5-β6 unit, and the
breaking of this interaction must take place upon β bar-
rel opening. Earlier, it was shown that mutation of
Glu72 to Ser caused destabilization of heart FABP [60].
Conclusions
Phe57 is a residue linking the β-turn loops β3-β4 and
β5-β6 and helix α2 in the portal region of P2, and in
other FABPs. It interacts directly with the bound fatty
acid, and it is likely to play a role in the regulation of
portal region opening upon membrane contact. The
opening of the β barrel observed in simulations of
P2-F57A reveals a mechanism for FABP ligand exchange
that has been long suggested [56], but was only recently
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shown for the CMT disease mutants of P2 [11]. The dis-
continuity of the FABP β barrel is likely to be instrumen-
tal for its opening upon ligand binding - also highlighted
by the fact that the hot spot for CMT mutations lies in
close vicinity to the opening site in P2, on strands β3
and β4. Comparing all human FABPs, we earlier showed
that only two Gly residues are fully conserved in all fam-
ily members [12]; of these, Gly67 lies in the β4-β5 loop
(Fig. 3c), which may act as a functional hinge in the
FABP superfamily during barrel opening.
Additional files
Additional file 1: Figure S1. DCCM analyses on earlier MD trajectories
from P2 mutants. A. P38G. B. I42N. C. T50P. D. I51T. The empty structures
are on the left and the palmitate-bound on the right. (PNG 3329 kb)
Additional file 2: Figure S2. Comparison of centrality analyses between
wt-P2 and P2-F57A mutants. A residue interaction network (top) was
generated from the crystal structures of P2 (bottom), and central residues
were mapped onto them. A. Central residues globally conserved between
wt-P2 and different P2-F57A mutant structures. Residues are considered
central if their Z score ≥ 2, and they are coloured in the network as a
function of this Z score with a gradient from yellow (Z score = 2) to red
(Z score ≥ 4). Z score values of the wt-P2 were chosen for these Figs. B.
Central residues only identified in one or several F57A mutant structures
and not in wt-P2. Yellow is indicative of Z score ≥ 2. (PDF 1416 kb)
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